Iodine deficiency and excess in children: worldwide status in 2013
FDA-approved options are available
Patient Population The majority of patients who can tolerate semaglutide would be expected to have at least some weight loss from taking the drug, and according to the clinical expert, patients who report significant hunger and difficulty reducing portion sizes tend to be the patients who respond the most to the drug, although some weight loss is also seen in patients who do not report significant hunger or overeating
Most experts recommend prioritizing protein at every meal to help preserve muscle during weight loss
Those who reported no improvement in global well-being had a minimal change in vitamin B12 levels, no significant improvement in the physical functioning scale of the RAND-36, no significant increase in number of steps, and no significant improvement in the CIS20r fatigue scale
Research consistently shows that gradual dose escalation leads to better one-year adherence rates
